(Q43636686)

25 November 2017

An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression (English)

1 reference

25 November 2017

1 reference

0 references

Shih YF

1

1 reference

25 November 2017

Hsiao CK

2

1 reference

25 November 2017

Chen CJ

3

1 reference

25 November 2017

Chang CW

4

1 reference

25 November 2017

Hung PT

5

1 reference

25 November 2017

Lin LL

6

1 reference

25 November 2017

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

79

1 reference

25 November 2017

3

1 reference

25 November 2017

233-236

1 reference

Inhibition of physiological growth hormone secretion by atropine.

25 November 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.790304.X

The treatment of myopia with atropine and bifocals. A long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.790304.X

7 January 2021

The effectiveness of 0.5% atropine in controlling high myopia in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.790304.X

7 January 2021

Rates of childhood myopia progression with bifocals as a function of nearpoint phoria: consistency of three studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.790304.X

7 January 2021

Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.790304.X

7 January 2021

Effects of different concentrations of atropine on controlling myopia in myopic children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.790304.X

7 January 2021

The effect of intravitreal injection of atropine on the proliferation of scleral chondrocyte in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.790304.X

7 January 2021

10.1034/J.1600-0420.2001.790304.X

Identifiers

DOI

1 reference

25 November 2017

1 reference